Applying Principles of Regenerative Medicine to Vascular Stent Development - PubMed (original) (raw)
Review
Applying Principles of Regenerative Medicine to Vascular Stent Development
Prakash Parthiban Selvakumar et al. Front Bioeng Biotechnol. 2022.
Abstract
Stents are a widely-used device to treat a variety of cardiovascular diseases. The purpose of this review is to explore the application of regenerative medicine principles into current and future stent designs. This review will cover regeneration-relevant approaches emerging in the current research landscape of stent technology. Regenerative stent technologies include surface engineering of stents with cell secretomes, cell-capture coatings, mimics of endothelial products, surface topography, endothelial growth factors or cell-adhesive peptides, as well as design of bioresorable materials for temporary stent support. These technologies are comparatively analyzed in terms of their regenerative effects, therapeutic effects and challenges faced; their benefits and risks are weighed up for suggestions about future stent developments. This review highlights two unique regenerative features of stent technologies: selective regeneration, which is to selectively grow endothelial cells on a stent but inhibit the proliferation and migration of smooth muscle cells, and stent-assisted regeneration of ischemic tissue injury.
Keywords: bioabsorable; reendothelialization; restenosis; selective regeneration; stent.
Copyright © 2022 Selvakumar, Rafuse, Johnson and Tan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
FIGURE 1
Outcomes of endovascular stents. (Top panel) Stents produce undesired outcomes such as in-stent thrombosis and in-stent restenosis. In-stent thrombosis involves accumulation of platelets and presence of fibrinogen. In-stent restenosis causes narrowing of the lumen greater than 50% due to the overgrowth of smooth muscle cells with neointima formation. (Botton panel) The ideal vascular regeneration with stents will have a fully developed endothelial monolayer lining the lumen with either the stent completely bioabsorbed or permanently encapsulated in the intimal layer.
FIGURE 2
Two generation mechanisms using surface functionalizations to override drug inhition effects on stent endothelialization. (A) Regeneration from adjacent cells, which can involve the functionalization of stents with angiogenic peptide or NO producing coating. (B) Regeneration from blood-borne cells, which can involve the functionalization of stents with certain cell-capture antibodies, adhesive peptide or growth factor.
Similar articles
- Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
Curcio A, Torella D, Indolfi C. Curcio A, et al. Circ J. 2011;75(6):1287-96. doi: 10.1253/circj.cj-11-0366. Epub 2011 Apr 29. Circ J. 2011. PMID: 21532177 Review. - Multi-functional plant flavonoids regulate pathological microenvironments for vascular stent surface engineering.
Liu L, Lan X, Chen X, Dai S, Wang Z, Zhao A, Lu L, Huang N, Chen J, Yang P, Liao Y. Liu L, et al. Acta Biomater. 2023 Feb;157:655-669. doi: 10.1016/j.actbio.2022.11.035. Epub 2022 Nov 25. Acta Biomater. 2023. PMID: 36436757 - Drug-eluting stents.
García-García HM, Vaina S, Tsuchida K, Serruys PW. García-García HM, et al. Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Arch Cardiol Mex. 2006. PMID: 17091802 Review. - Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces.
Yang Z, Zhao X, Hao R, Tu Q, Tian X, Xiao Y, Xiong K, Wang M, Feng Y, Huang N, Pan G. Yang Z, et al. Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16127-16137. doi: 10.1073/pnas.2003732117. Epub 2020 Jun 29. Proc Natl Acad Sci U S A. 2020. PMID: 32601214 Free PMC article. - Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.
Ceresnakova M, Murray D, Soulimane T, Hudson SP. Ceresnakova M, et al. Eur J Pharmacol. 2021 Nov 5;910:174490. doi: 10.1016/j.ejphar.2021.174490. Epub 2021 Sep 4. Eur J Pharmacol. 2021. PMID: 34492283
Cited by
- Recent advances in surface functionalization of cardiovascular stents.
Wang C, Lv J, Yang M, Fu Y, Wang W, Li X, Yang Z, Lu J. Wang C, et al. Bioact Mater. 2024 Oct 28;44:389-410. doi: 10.1016/j.bioactmat.2024.10.025. eCollection 2025 Feb. Bioact Mater. 2024. PMID: 39539518 Free PMC article. Review. - Camouflaging endovascular stents with an endothelial coat using CD31 domain 1 and 2 mimetic peptides.
Sénémaud J, Skarbek C, Hernandez B, Song R, Lefevre I, Bianchi E, Castier Y, Nicoletti A, Bureau C, Caligiuri G. Sénémaud J, et al. JVS Vasc Sci. 2024 Jul 23;5:100213. doi: 10.1016/j.jvssci.2024.100213. eCollection 2024. JVS Vasc Sci. 2024. PMID: 39257386 Free PMC article.
References
- Alexander G. C., Hwang P. T. J., Chen J., Kim J., Brott B. C., Yoon Y. S., et al. (2018). Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion under Physiologic Conditions. ACS Biomater. Sci. Eng. 4, 107–115. 10.1021/acsbiomaterials.7b00676 - DOI - PMC - PubMed
- Banerjee S., Jeon-Slaughter H., Armstrong E. J., Bajzer C., Abu-Fadel M., Khalili H., et al. (2019). Clinical Outcomes and Cost Comparisons of Stent and Non-stent Interventions in Infrainguinal Peripheral Artery Disease: Insights from the Excellence in Peripheral Artery Disease (XLPAD) Registry. J. Invasive Cardiol. 31, 1–9. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources